Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...
During the House Oversight hearing earlier this summer, Conway, Kautzner and Joyner defended PBM business practices in front of a generally unfriendly panel of lawmakers. PBMs, middlemen that sit ...
The analysis, released in the Journal of the American Medical Association, finds that CVS Health's Caremark holds the largest market share overall in the PBM space. However, it led by the largest ...
The News & Observer UNC Health has launched its own pharmacy benefit manager (PBM) to serve employers in North and South Carolina. UNC Health has been using this PBM to manage prescriptions for ...
Supporters of the bill have argued it could lower costs, while opponents have warned it might drive up insurance premiums and weaken PBM bargaining power, according to the report. Mr. Newsom has ...
The AMA's report, released Sept. 9, found that CVS Health, OptumRx, Express Scripts and Prime Therapeutics control 70% of the national PBM market, according to a news release shared with Becker's.
The University of North Carolina-affiliated health system announced a plan this month to launch UNC Health Pharmacy Solutions, a "transparent" PBM for employers seeking an alternative to CVS ...
Collectively, they control 80% of the PBM market. All three are also part of large, vertically integrated healthcare companies. Caremark is a subsidiary of CVS Health and a sister company to ...
Their parent companies CVS, Cigna and UnitedHealth all include a major PBM, health insurer and pharmacy network. That vertical integration incentivizes and gives the conglomerates the ability to ...
For years, PBMs have described themselves as partners of health care plans and self-insured employers in the management of their respective prescription drug benefits. Likewise, pharmacy directors ...
During the hearing, the PBM executives said that they do not steer patients to their own pharmacies or pay them more favorable rates. Comer said those statements contradicted evidence unearthed by ...